drugset / Trial / NCT03630341

Adding L-Carnitine to Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovary Syndrome

NCT03630341

Phase 4 Completed 150 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Polycystic ovary syndrome is one of the most common endocrine disorders, affecting about 6-10% of women in their reproductive age. Anovulation and hyperandrogenism are often present together with hyperinsulinaemia and insulin resistance

Timeline

Start
2016-02-01
Primary completion
2018-03-31
Completion
2018-05

Drugs

EvaluationDrugModalityDoseRoute
Subject L-carnitine Other / unclassified 1000 mg Oral
Background Clomiphene Other / unclassified 50 mg Oral